… not only pregnant subjects, but also non-pregnant controls. The objective of this analysis was
to utilize a population pharmacokinetic approach to model the pharmacokinetics of oral AS, …

… artesunate and dihydroartemisinin using the final simultaneous population pharmacokinetic
artesunate-dihydroartemisinin … lower compared with non-pregnant patients with acute …

… on population pharmacokinetic modeling of artesunate and dihydroartemisinin in pregnant
and non-pregnant … Women in their second and third trimester of pregnancy and non-pregnant …

… been reported for artemether/dihydroartemisinin[9], artesunate/dihydroartemisinin[10], … As
there was no non-pregnant control group, pregnancy could not be evaluated as a categorical …

… dihydroartemisinin. The aim of this study was to investigate the population pharmacokinetics
of piperaquine in pregnant … of pregnancy for artesunate, artemether, dihydroartemisinin, …

… 4 times lower than in non-pregnant adults, respectively. The … not very different in pregnant
women and non-pregnant patients. … with artesunate in pregnant compared with non-pregnant …

… for the pregnant group was less than the non-pregnant controls. The findings of this study
suggest that additional studies on the pharmacokinetics of AS in pregnant women are needed. …

… effect of pregnancy on its pharmacokinetic properties. … pharmacokinetic properties of
mefloquine/carboxymefloquine and artesunate/dihydroartemisinin in pregnant and non-pregnant …

… In this study, a population pharmacokinetic model was developed for artesunate and
dihydroartemisinin in pregnant and non-pregnant women in Burkina Faso, treated with a fixed-dose …

… in non- pregnant women based on PK parameters in 2 published pooled population PK
meta… after dosing in the artesunate- amodiaquine and dihydroartemisinin- piperaquine groups, …